Humana analyst target implies 10.2% upside
Alpha Vantage · Barron's · · AI-summarised by FinFlash
Humana Inc. carries an average analyst price target of $465.12 against a price of $422.07, implying roughly 10.2% upside. Ratings split at 13 Buy, 12 Hold and 1 Sell. The Vienna-listed quote shows a delayed €0.00 print, with an average target of €460.46. The divided analyst view suggests limited conviction, so investors should weigh the modest upside against mixed sentiment.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.